María J. Gonzalez-Rellan

Author

Instituto de Investigación Sanitaria de Santiago ORCID

Also Known As

Maria Jesús Gonzalez-Rellan, Maria J Gonzalez-Rellan, Maria J. Gonzalez-Rellan, Maria J. Gonzalez‐Rellan, Maria J. González-Rellan, María J. Gonzalez-Rellan, María Jesús González-Rellán

Publications

681

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Sanitaria de Santiago Universidade de Santiago de Compostela CIC bioGUNE Xunta de Galicia Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

About

María J. Gonzalez-Rellan is an author at Instituto de Investigación Sanitaria de Santiago specializing in metabolic syndrome, oxidative stress, and molecular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	31
2	Medicine	1	1	31
3	Biochemistry	1	1	31
4	Cell Biology	1	1	31
5	Endocrinology	1	1	31

María J. Gonzalez-Rellan

Publications

549

Citations

H-Index

Page 1

	Year	Citations
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis Marcos F. Fondevila, Uxia Fernandez, Violeta Heras, Journal of Hepatology	2022	99
O-GlcNAcylated p53 in the liver modulates hepatic glucose production María J. Gonzalez-Rellan, Marcos F. Fondevila, Uxia Fernandez, Nature Communications	2021	70
The L‐α‐Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis Marcos F. Fondevila, Uxia Fernandez, María J. Gonzalez-Rellan, Hepatology	2020	59
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis Marina Serrano‐Maciá, Jorge Simón, María J. Gonzalez-Rellan, Molecular Metabolism	2021	49
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism María J. Gonzalez-Rellan, Uxía Fernández, Tamara Parracho, Cell Metabolism	2023	46
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function Natália da Silva Lima, Marcos F. Fondevila, Eva Nóvoa, Journal of Hepatology	2021	43
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis Begoña Porteiro, Marcos F. Fondevila, Xabier Buqué, Molecular Metabolism	2017	34
Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease Beatriz Gómez‐Santos, Diego Sáenz de Urturi, Maitane Núñez-García, Aging Cell	2020	32
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting Alba Capelo-Diz, Sofía Lachiondo‐Ortega, David Fernández‐Ramos, Cell Metabolism Adaptive Cellular ResponsesMetabolic RemodelingOxidative StressMetabolic SyndromeHepatotoxicity	2023	31
Pharmacological and Genetic Manipulation of p53 in Brown Fat at Adult But Not Embryonic Stages Regulates Thermogenesis and Body Weight in Male Mice Omar Al–Massadi, Begoña Porteiro, Doreen Kuhlow, Endocrinology	2016	25

Page 1